Akademska digitalna zbirka SLovenije - logo
E-viri
Recenzirano Odprti dostop
  • Immune responses to SARS-Co...
    Tosif, Shidan; Neeland, Melanie R; Sutton, Philip; Licciardi, Paul V; Sarkar, Sohinee; Selva, Kevin J; Do, Lien Anh Ha; Donato, Celeste; Quan Toh, Zheng; Higgins, Rachel; Van de Sandt, Carolien; Lemke, Melissa M; Lee, Christina Y; Shoffner, Suzanne K; Flanagan, Katie L; Arnold, Kelly B; Mordant, Francesca L; Mulholland, Kim; Bines, Julie; Dohle, Kate; Pellicci, Daniel G; Curtis, Nigel; McNab, Sarah; Steer, Andrew; Saffery, Richard; Subbarao, Kanta; Chung, Amy W; Kedzierska, Katherine; Burgner, David P; Crawford, Nigel W

    Nature communications, 11/2020, Letnik: 11, Številka: 1
    Journal Article

    Compared to adults, children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have predominantly mild or asymptomatic infections, but the underlying immunological differences remain unclear. Here, we describe clinical features, virology, longitudinal cellular, and cytokine immune profile, SARS-CoV-2-specific serology and salivary antibody responses in a family of two parents with PCR-confirmed symptomatic SARS-CoV-2 infection and their three children, who tested repeatedly SARS-CoV-2 PCR negative. Cellular immune profiles and cytokine responses of all children are similar to their parents at all timepoints. All family members have salivary anti-SARS-CoV-2 antibodies detected, predominantly IgA, that coincide with symptom resolution in 3 of 4 symptomatic members. Plasma from both parents and one child have IgG antibody against the S1 protein and virus-neutralizing activity detected. Using a systems serology approach, we demonstrate higher levels of SARS-CoV-2-specific antibody features of these family members compared to healthy controls. These data indicate that children can mount an immune response to SARS-CoV-2 without virological confirmation of infection, raising the possibility that immunity in children can prevent the establishment of SARS-CoV-2 infection. Relying on routine virological and serological testing may not identify exposed children, with implications for epidemiological and clinical studies across the life-span.